JHL Biotech Inc., a Taiwan-based developer of cheaper alternative cancer drugs, has raised a new round of financing at a valuation of about $750 million, a person with knowledge of the matter said. Mo…
( read original story …)
The Taiwan NEWS
JHL Biotech Inc., a Taiwan-based developer of cheaper alternative cancer drugs, has raised a new round of financing at a valuation of about $750 million, a person with knowledge of the matter said. Mo…
( read original story …)